Skip to content

Nutritional intervention in bipolar disorder and schizophrenia

The effects of diet on metabolic and mental health outcome measures in bipolar disorder and schizophrenia: a randomized controlled clinical trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12623000854639
Enrollment
100
Registered
2023-08-08
Start date
2023-09-04
Completion date
2024-09-02
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Adult community participants with a diagnosis of either bipolar disorder, schizophrenia, or schizoaffective disorder will be randomized to a dietary intervention alongside their treatment as usual. Participants will be assessed for their metabolic health, and social and mental functioning and supported with education and assistance in ensuring adherence to the allocated dietary protocol.

Interventions

The intervention group ("the KD arm") will be asked to follow a well-formulated and nutritionally balanced ketogenic diet (75% fat, 20% protein and 5% carbohydrates) for 12 weeks (+2 weeks introduction "run-in" to the diet and +2 weeks cessation period), taking into account the participants food preferences, allergies and intolerances, food preparation abilities and financial circumstances. The definition of "ketogenic" is based on the ability of the diet to induce the physiological production o

The intervention group ("the KD arm") will be asked to follow a well-formulated and nutritionally balanced ketogenic diet (75% fat, 20% protein and 5% carbohydrates) for 12 weeks (+2 weeks introduction "run-in" to the diet and +2 weeks cessation period), taking into account the participants food preferences, allergies and intolerances, food preparation abilities and financial circumstances. The definition of "ketogenic" is based on the ability of the diet to induce the physiological production of ketone bodies ("ketones") by the liver in response to the diminished carbohydrate intake. Such ability is a natural physiological response and as such varies in accordance to the participants' sex, underlying metabolic state and long-standing dietary habits. During the 2-week run-in period, the participant will for the first five days be required to only change their breakfast meal. On day six, the participants will be required to change the lunch meal as well (at this point, they are on their specified diet both morning and lunch). On day eleven, the dinner meal will be required to be changed into the specified diet, resulting in a complete change of diet. Similarly, during the cessation period, the participant will start by changing one meal back to "normal" for 5 days, then 2 meals and after 11 days, the participant will be back to their previous dietary habits. If the participant decides to continue the diet after the study has ended, they will not be required to stop it after week 14. Support from a dietitian and a team member will be offered for up to 3 months. The KD arm will therefore receive an individualised nutritional assessment and advice by a qualified dietician experienced in therapeutic KD that will maximise the efficacy and safety of the KD in each case. The assessment will occur as soon as possible following the randomisation into the treatment group and will last approximately 60 minutes. Following the assessment, the participants in the KD arm will receive informational material in the form of a KD Handbook (designed specifically for this study) containing the principles of the diet; necessary information to understand different macro and micronutrients relevant to the diet; education around the most common side effects of being on a KD and how to manage them; a collection of illustrated, easy to follow recipes to help the participants' daily compliance with the diet; Daily readings of peripheral blood ketone and blood glucose levels will be monitored in order to ensure safety of, and compliance with, the diet. The participants will be asked to text a picture of their digital device showing ketones and blood sugar levels; as an optional alternative, they may send a text with the results to the team or receive a phone call by a team member instead. With appropriate consent in place, family members and/or carers will be encouraged to support the participant with their food sourcing, meal preparation, and blood test monitoring. If necessary, in view of poor adherence to the diet by a participant or at the participant's own request, additional education by a team member under strict supervision of the dietitian and senior psychiatrists in the team, will be delivered to the participants or to their families or carers to ensure adherence to the KD.

Sponsors

James Cook University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1) Meet the DSM-4 diagnostic criteria for bipolar disorder or meet the DSM-5 diagnostic criteria for schizophrenia for at least 6 months, assessed using the MINI Neuropsychiatric Interview 2) Clinically stable is defined as 3 months with no relapses. 3) Able to provide informed consent to take part in the study. 4) Able to speak, read and understand English to a level whereby they can understand the participant information sheet (PIS). 5) Able to understand basic principles of the specific diet 6) Ability to complete an accurate diet and symptom diary as well as questionnaires required.

Exclusion criteria

1) Pregnancy or breastfeeding (or those planning to become pregnant within 3 months) 2) Active substance misuse with alcohol or illicit drugs 3) Use of the ketogenic diet in the previous 2 months 4) Currently following a vegan diet 5) Admission to a hospital within the past 3 months 6) Current involvement in another research study (This feasibility study is of moderate intensity and requires daily monitoring and a significant dietary intervention requiring careful planning. As such it would not be appropriate for participants involved in other current research to take part due to the potentially high level of burden on them. Those involved in recent research that has ended by the time of recruitment to this study would be eligible, and will be made fully aware of the level of engagement required to allow them to make an informed decision) 7) Inability to complete week 0 assessments 8) Clinically significant liver or kidney disease 9) Clinically significant cardiovascular disease 10) Severe hyperlipidemia 11) Type 1 diabetes 12) History of eating disorder 13) BMI < 18.5kg 14) On medication that can cause ketosis 15) Not willing to change diet or unable to change diet due to medical reasons 16) No access to cooking facilities and ingredients to prepare recipes following the specific diet.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026